Introduction
Systemic sclerosis (SSc) is a systemic connective tissue disease characterized by inflammation, widespread vascular lesions and fibrosis involving various organs including the lungs, skin, gastrointestinal tract, kidneys, and heart. 1 In particular, cardiopulmonary involvement in SSc is associated with an unfavourable prognosis 1,2 -particularly pulmonary hypertension (PH). [3] [4] [5] [6] [7] [8] [9] [10] Although pathologic observations at necropsy have demonstrated myocardial involvement in around 50-80% of patients with SSc, [11] [12] [13] clinical evidence of myocardial dysfunction using conventional diagnostic modalities has not been widely recognized. 1, 14, 15 New techniques for the assessment of myocardial deformation have proven to be more sensitive than conventional echocardiography for the prediction of outcomes. 16 Several strain studies have demonstrated not only right ventricular (RV) but also left ventricular (LV) dysfunction in SSc, although the severity of LV dysfunction was relatively mild, 17 even with the use of sophisticated methods. [6] [7] [8] 10 The prognostic impact of this observation is unclear, as is its independence from RV dysfunction associated with pulmonary vascular disease, particularly as the LV and RV share several anatomical structures. 18, 19 The purpose of this study was to investigate the mechanism of LV dysfunction, and its prognostic value compared with RV function in patients with SSc.
Methods

Study design
In this retrospective cohort study, we identified 116 consecutive patients with SSc without significant ischaemic and valvular heart disease, who underwent echocardiography between July 2005 and June 2014.
In patients with multiple echocardiograms, the first report on the system was selected as the baseline. The diagnosis of SSc was based on the American Rheumatism Association's criteria and confirmed by view of each medical record. 20 After the exclusion of 9 patients with atrial fibrillation and 4 patients due to inadequate echocardiographic image quality, 103 age-and gender-matched control patients without significant cardiac disease (e.g. routine studies before non-cardiac surgery) were identified, then clinical details were confirmed by viewing each medical record. The study was approved by the Tasmanian Health Research Ethics Committee as a low risk protocol based on data linkage without the need for individual consent.
Clinical data
Clinical parameters (comorbidities, medications, vital signs, serum markers) at the time of echocardiography were comprehensively assessed by reviewing each medical record. The data of 6-minute walk distance (6MWD), lung function test, and right heart catheterization (RHC) at the date closest to the echocardiogram were also collected in patients with SSc.
Echocardiography
The earliest data stored in the echocardiography database was used for analysis. Transthoracic echocardiography was performed by experienced sonographers using a commercially available ultrasound machine (Vivid 7, Vivid 9, or Vivid i; GE Vingmed, Horten, Norway). Echocardiographic images were digitally recorded and downloaded as DICOM files for offline analysis. All echocardiographic parameters including strain were analysed by a single core reader, blinded to the other data. Conventional echocardiographic parameters were measured according to the recommendations of the American Society of Echocardiography. 21, 22 LV volumes and LV ejection fraction (EF)
were calculated by the modified Simpson method using 2D images and LV volumes were indexed to body surface area. LV mass was calculated according to the American Society of Echocardiography formula, and normalized to body surface area. Left atrial volume was calculated by the modified Simpson's method using 2D images and indexed to body surface area. The transmitral early diastolic velocity (E) was acquired in the apical 4-chamber view using pulsed-wave Doppler at the level of the mitral valve tips during diastole. The early diastolic mitral annular tissue velocity (e 0 ) was also measured in the apical 4-chamber view with the sample volume positioned at both the septal and lateral mitral annulus and being the average of these two values. The combined assessment of E and e 0 was used to calculate E/e 0 . The peak pressure gradient between RV and right atrium (TRPG) was also measured on the continuous-wave spectral Doppler signal of tricuspid regurgitation. Systolic pulmonary artery pressure (SPAP) was estimated from TRPG and the maximum inferior vena cava diameter and its collapsibility. 23 In addition, pulmonary vascular resistance (PVR) was also calculated from peak tricuspid regurgitant velocity and RV outflow tract time velocity integral. 24 
LV strain and tricuspid annular velocity
We measured the two global strain parameters [global longitudinal strain (GLS) and global circumferential strain (GCS)] using standard methodologies for speckle tracking (Research Arena, Tomtec, Germany). 25 After manual tracing of the LV endocardial border, the dedicated software automatically tracked the myocardium throughout the cardiac cycle. Peak values of segmental longitudinal strain were obtained from gray scale-recorded images in the apical 4-chamber, 2-chamber, and long-axis views and GLS was obtained by averaging these peak values. 26 The peak values of the six segmental circumferential strain curves were obtained from the short-axis view at the papillary muscle level and averaged to provide GCS. Similarly, using speckle tracking, tricuspid annular peak systolic and early diastolic velocities (Ts 0 and Te 0 ) were measured from the RV apical 4-chamber view. The mean frame rate was 54 ± 21 frames/s.
Follow-up
The primary outcome was unplanned admission with heart failure (HF) or death after the index echocardiogram. Outcome was confirmed from each medical record. Patients were censored at the time of outcome or at the end of follow-up.
Statistical analysis
Data were expressed as mean ± SD or median (inter-quartile range). Overall, <5% of observations were missing, with the exception of Ts 0 and Te 0 (14%), lung function parameters (45%), and RHC data (45%).
Missing Ts 0 and e 0 were imputed from propensity models using parameters without missing data (age, gender, body mass index, systolic blood pressure, heart rate, LV mass index, e 0 , E/e 0 , LA volume index, GLS, SPAP, diabetes mellitus, serum creatinine, atrial fibrillation, haemoglobin). Other continuous variables (<5%) were imputed using the corresponding mean value. The significance of differences between the groups was assessed using Student's t-test or MannWhitney U test according to the distribution of the study parameters. For categorical variables, the v 2 test or Fisher's exact test were used, as appropriate. Univariable quadratic regression analysis was used to evaluate the associations between LV strain parameters and SPAP because it had better fit than a simple linear regression model. Univariable and multiple Cox proportional-hazards models were used to determine the features associated with the outcome. The optimal model was selected based on the significant variables in the univariable analysis and clinically relevant parameters. The incremental value of Ts 0 was assessed in two modelling steps, using nested models. The first step consisted of fitting a multivariable model of age, gender, 6MWD, and GCS. Then, Ts 0 was included in the second step.
The change in overall log-likelihood ratio v 2 was used to assess the increase in predictive power after the addition of Ts 0 , and Harrell's C statistic was used to evaluate model performance. The receiver operating characteristic (ROC) curve was used to determine the optimal cut-off values of GCS, Ts 0 , and 6MWD for predicting the outcome.
Comparisons of AUC in each parameter were performed with the method proposed by DeLong et al. 27 Reclassification was evaluated to assess the incremental benefit of adding Ts 0 to the model based on age, gender, 6MWD, and GCS with continuous net reclassification improvement (NRI) methods and integrated diagnostic improvement (IDI). Inter-and intraobserver variabilities were examined for GLS, GCS, and Ts 0 using the intraclass and interclass correlation coefficients.
Measurements were performed in a group of 10 randomly selected subjects by 1 observer, then repeated on 14 separate days by 2 observers. Statistical analysis was performed using standard statistical software packages [SPSS software 20.0, SPSS Inc., Chicago, IL and R software ver.3.0.2 (http://cran.r-project.org/)], and statistical significance was defined by P <0.05.
Results
Clinical characteristics Table 1 summarizes the clinical characteristics in the patients with SSc and controls. Patients with SSc had significantly higher heart rate and prevalence of chronic lung disease, and lower blood pressure and less use of anti-hypertensive agents. About half of the SSc patients were treated with pulmonary vasodilators. The performance of lung function testing and RHC was incomplete in SSc patients. Although based on limited data, their %DLCO appeared to be more impaired than forced vital capacity and forced expiratory volume in 1 s. Table 2 shows a comparison of echocardiographic parameters, most of which were within the normal range. Although LV volume, ejection fraction, and diastolic parameters were not significantly different between the groups, pulmonary haemodynamics, RV function, and LV strain parameters were significantly worse in patients with SSc compared with controls. These results were consistent even in SSc patients with SPAP <40 mmHg and no administration of drugs for PH (n = 40, see Supplementary data online, Tables S1 and S2 ACEi/ARB, n (%) 11 (11) 24 ( 
Echocardiographic characteristics
Events
During follow-up (median 3.4 years [IQR 1.8-6.3]), SSc patients (n = 17, 17%) were more likely to develop HF-specific admission or death compared with controls (n = 7, 7%, P = 0.04). Of SSc patients with the primary outcome, eight patients were admitted due to HF and nine patients died. In the case of SSc patients without PH (n = 40), only one patient had an event.
Associations of outcome use, shorter 6MWD, impaired lung function, higher mean pulmonary artery pressure, SPAP and PVR, worse GCS and Ts 0 . LV diastolic function parameters and GLS were not significantly associated with outcome. In the ROC analysis for predicting primary outcome, the discriminative ability of 6MWD (AUC = 0.81) was non-significantly greater than those of GCS (AUC = 0.65, P = 0.09) and Ts 0 (AUC = 0.67, P = 0.07) (Figure 3 ). There was no significant difference of AUCs between Ts 0 and GCS (P = 0.78). The optimal cut-point for GCS was -25.2% (sensitivity 63%, specificity 70%), for Ts 0 5.9 cm/s (sensitivity 69%, specificity 65%), and for 6MWD 429 m (sensitivity 94%, specificity 66%).
Independence and incremental value of RV and LV function for outcome
After the adjustment with 6MWD, Ts 0 was significantly associated with HF-specific admission or death but GCS was not ( Table 4) . In sequential Cox models for predicting outcome in patients with SSc, the model based on age, gender, 6MWD, and GCS was significantly improved by adding Ts 0 (C-statistic 0.80 to 0.84, P = 0.02). Further, addition of Ts 0 led to trend towards reclassification improvement (Continuous NRI: 0.59, P = 0.06).
Influence of the aetiology of PH on ventricular function and prognosis in SSc
Of 56 patients having RHC, a definite diagnosis of PH (mean pulmonary artery pressure > _25 mmHg) was observed in 54 patients. Further, of 54 patients with PH, pulmonary artery hypertension (PAH) (mean pulmonary capillary wedge pressure <15 mmHg) was recognized in 51 patients, with the remaining 3 patients considered to have PH due to left heart disease. Of 51 patients with PAH, the 14 with lung disease had higher SPAP (38 mmHg vs. 27 [IQR 22-33] mmHg, P = 0.07) and impaired GCS (-24.7 ± 4.9% vs.
-27.9 ± 4.9%, P = 0.046) and Ts 0 (5.6 ± 2.1% vs. 6.9 ± 1.8%, P = 0.04) than those without lung disease. In addition, the incidence of primary outcome was significantly higher in patients with lung disease than those without (57% (8/14) vs. 5% (2/37) mmHg, P < 0.01). Importantly, however, Ts 0 was associated with primary outcome even after the adjustment of involving lung disease (hazard ratio 0.64 (95% CI 0.42-0.96), P = 0.03).
Reproducibility
The intraclass and interclass correlation coefficients were; 0. 
Discussion
The present study demonstrates the relative prognostic value of RV and LV dysfunction in SSc patients, and points towards a mechanism for linking these features. Similar to previous reports, LV deformation in SSc-while reduced compared with controls-was within the normal range. GCS appeared to be more affected by increased systolic RV pressure and associated with adverse outcome than GLS. GCS was associated with outcome. However, the association appeared to be mediated by RV function, and RV systolic function and 6MWD showed the only independent association with outcome in SSc.
Mechanism of LV dysfunction in SSc
SSc is a systemic connective tissue disease characterized by inflammation and fibrosis involving distinct target organs. 1 Histological studies have shown myocardial fibrosis in up to 80% of patients with SSc, 13 and myocardial fibrosis has been considered as the main mechanism of LV dysfunction. In the present study, a mild deterioration of LV Figure 2 The relationships between global longitudinal strain, global circumferential strain, and systolic pulmonary artery pressure in patients with systemic sclerosis. Dotted line shows 95% confidence interval. The deterioration of segmental strain in the septal segments, likely affected by both LV and RV function, appeared to contribute to the impairment of global strain. In addition, GCS was weakly associated with increased SPAP. These results suggest that LV dysfunction could be affected by not only LV myocardial fibrosis but also by RV dysfunction and pulmonary haemodynamics, reflecting ventricular interdependence in patients with SSc. In addition to its association with RV longitudinal systolic deformation, RV pressure overload influences the interventricular septum and LV geometry. This impairs LV torsion and segmental longitudinal and circumferential strain, more for the septum than for the free wall of the LV. 18 These findings are supportive of our observations; in the present study, SSc patients had significantly higher PVR, and half of the patients were treated by the drugs for PH, which could reflect chronic RV pressure overload.
Prognostic value of LV dysfunction in SSc
RV dysfunction, usually caused by vascular and interstitial lung disease resulting in PH, has been frequently reported, and strongly associated with adverse outcomes in SSc patients, 1,2,31,32 which was consistent with the present results based on RHC data. The present study also demonstrated that RV dysfunction was associated with adverse outcome, independent of and incremental to functional capacity and LV deformation parameters in SSc. However, LV dysfunction was not independently associated with outcome, implying that its univariable association was mediated by RV dysfunction. From the above, these results suggest that the predictive power of LV dysfunction seems to be weaker than RV dysfunction in SSc, although this could depend on the severity and condition of PH in the study cohort. In addition, there was only one adverse event in SSc patients without PH, which might suggest that the events were mainly associated with RV failure throughout PH. Further, SSc patients with risk factors for RV failure such as the use of diuretics, decreased 6MWD, and impaired lung function led to more adverse events, which might support the idea that RV failure was the primary cause of the events. Therefore, impaired LV and RV dysfunction might be considered to be the consequence of RV failure. Recently, the cost-effectiveness of adapting myocardial deformation parameters for early detection and intervention of LV dysfunction has been investigated. 33 In the present study, abnormal LV deformation in SSc patients had limited prognostic value compared with RV dysfunction, and its effectiveness and cost-effectiveness are unclear. In contrast, the assessment of RV function is a crucial step for effective management of PH. 34 The routine assessment of RV dysfunction in SSc patients might lead to early intervention, and a reduction of adverse events may lead to cost-savings.
Study limitations
Our data should be interpreted in the context of their limitations. First, our observational study carries the risk of unmeasured confounders. Figure 3 ROC curves for predicting heart failure-specific admission or death in patients with systemic sclerosis. GCS indicates global circumferential strain; Ts 0 , tricuspid annular peak systolic velocity; 6MWD, 6-minute walk distance; 95% CI, 95% confidence interval.
